Skip to content

High prevalence of asymptomatic TB in HIV patients in Cape Town

Low CD4 cell count increases risk of non-AIDS-defining cancers for patients on HIV therapy

Concerns about efficacy, cost and side-effects possible barriers to PrEP uptake in groups with high HIV risk

HIV damages B-cells as well as T-cells: new treatment targets identified

Large gaps in the HIV prevention evidence base

Tropism impacts on virological success of first-line HIV therapy

HIV tests every 3 to 6 months suggested for all sexually active gay men in US

Switch from efavirenz to raltegravir improves mood and lipid profiles

UNAIDS: Treat 15 million by 2015